Presentations
December 2022
CD123 Directed IgM T-cell Engager, IGM-2537, Demonstrates Potent in vitro and in vivo Activity with Minimal Cytokine Release
64th American Society of Hematology (ASH) Annual Meeting and Exposition — December 10-13, 2022
November 2022
Unleashing the Power of Valency: A broad coverage, Receptor Trapping mechanism realized by the IgM platform for the prevention and treatment of infectious diseases
World Antiviral Congress — November 28-December 1, 2022
April 2022
Enhanced NK and CD8+ T cell proliferation, tumor cytotoxicity and reversal of T cell exhaustion with IGM-7354, an anti-PD-L1 IgM antibody and IL-15 cytokine fusion
American Association for Cancer Research (AACR) Annual Meeting – April 8-13, 2022